Tyrosine Kinase Inhibitors: all 10,469 studies that test it

Page 46 of 105. Open to participants first (1,907), then studies with results posted, then the rest; newest registration first within each.

• Imatinib Mesylate (Gleevec) and Docetaxel in Patients With Head and Neck Squamous Cell CancerCompletedNCT00485485Phase 2Results posted
• Study of a JAK3 Inhibitor for the Prevention of Acute Rejection in Kidney Transplant PatientsCompletedNCT00483756Phase 2Results posted
• Gefitinib and Etoposide in Treating Patients With Advanced Prostate Cancer That Did Not Respond to Hormone TherapyTerminatedNCT00483561Phase 2Results posted
• Lenalidomide, Sunitinib, and Cyclophosphamide in Treating Patients With Stage IV Eye MelanomaTerminatedNCT00482911Phase 2Results posted
• A Study of Dasatinib in Chronic Phase Philadelphia Chromosome Positive Chronic Myeloid LeukemiaCompletedNCT00482703Phase 1/2Results posted
• Erlotinib Hydrochloride in Treating Patients With Pancreatic Cancer That Can Be Removed by SurgeryTerminatedNCT00482625Phase 2Results posted
• Phase 2 Anastrozole and Vandetanib (ZD6474) in Neoadjuvant Treatment of Postmenopausal Hormone Receptor-Positive Breast CancerTerminatedNCT00481845Phase 2Results posted
• A Phase III Study of Dasatinib vs Imatinib in Patients With Newly Diagnosed Chronic Phase Chronic Myeloid LeukemiaCompletedNCT00481247Phase 3Results posted
• Lapatinib In Combination With Chemotherapy In Subjects With Relapsed Breast CancerTerminatedNCT00479856Phase 2Results posted
• Iressa and Taxotere Study in Patients With Metastatic Urothelial CancerTerminatedNCT00479089Phase 2Results posted
• Sunitinib Malate in Treating Patients With Recurrent or Metastatic Endometrial CancerCompletedNCT00478426Phase 2Results posted
• Lapatinib in Combination With Capecitabine in Japanese Patients With Metastatic Breast CancerCompletedNCT00477464Phase 2Results posted
• Safety and Efficacy of Imatinib Mesylate in Patients With Pulmonary Arterial HypertensionCompletedNCT00477269Phase 2/3Results posted
• Erlotinib in Women With Squamous Cell Carcinoma of the VulvarCompletedNCT00476476Phase 2Results posted
• ALL Adult Consortium Trial: Adult ALL TrialCompletedNCT00476190Phase 2Results posted
• Cediranib Maleate in Treating Patients With Relapsed, Refractory, or Untreated Acute Myeloid Leukemia or High-Risk Myelodysplastic SyndromeCompletedNCT00475150Phase 2Results posted
• Sunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally Recurrent SarcomasCompletedNCT00474994Phase 2Results posted
• Dasatinib in Treating Patients With Metastatic Pancreatic CancerCompletedNCT00474812Phase 2Results posted
• Temsirolimus Versus Sorafenib As Second-Line Therapy In Patients With Advanced RCC Who Have Failed First-Line SunitinibCompletedNCT00474786Phase 3Results posted
• Systemic and Topical Treatments for Rash Secondary to Erlotinib in Lung CancerCompletedNCT00473083Phase 2Results posted
• Pazopanib in Treating Patients With Metastatic Urothelial CancerCompletedNCT00471536Phase 2Results posted
• A Study of Imatinib Versus Nilotinib in Adult Patients With Newly Diagnosed Philadelphia Chromosome Positive (Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP)CompletedNCT00471497Phase 3Results posted
• Efficacy and Safety of Nilotinib (AMN107) Compared With Current Treatment Options in Patients With GIST Who Have Failed Both Imatinib and SunitinibCompletedNCT00471328Phase 3Results posted
• Efficacy And Safety Of Sunitinib In Women With Advanced Breast CancerCompletedNCT00471276Phase 2Results posted
• Study Of Gemcitabine Plus AG-013736 Versus Gemcitabine For Advanced Pancreatic Cancer.CompletedNCT00471146Phase 3Results posted
• Lapatinib in Combination With Radiation Therapy in Patients With Brain Metastases From HER2-Positive Breast CancerCompletedNCT00470847Phase 1Results posted
• Lapatinib in Combination With Trastuzumab in Patients With HER2-Positive, Metastatic Breast CancerCompletedNCT00470704Phase 2Results posted
• Erlotinib in Treating Patients With Stage III or Stage IV Pancreatic CancerTerminatedNCT00470535Phase 2Results posted
• Imatinib Mesylate in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by SurgeryCompletedNCT00470470Phase 2Results posted
• Dasatinib in Treating Patients With Relapsed Small Cell Lung CancerCompletedNCT00470054Phase 2Results posted
• Lestaurtinib, Cytarabine, and Idarubicin in Treating Younger Patients With Relapsed or Refractory Acute Myeloid LeukemiaCompletedNCT00469859Phase 1/2Results posted
• Gefitinib and PEG-Interferon Alfa-2b in Treating Patients With Unresectable or Metastatic Kidney CancerTerminatedNCT00467077Phase 2Results posted
• Sorafenib Tosylate and Gene Expression Analysis in Patients Undergoing Surgery For High-Risk Localized Prostate CancerCompletedNCT00466752Phase 2Results posted
• Erlotinib and Bevacizumab in Treating Patients With Stage IV MelanomaCompletedNCT00466687Phase 2Results posted
• Sunitinib Malate in Patients With Non-Clear Cell Renal Cell CancerCompletedNCT00465179Phase 2Results posted
• Trial of Dasatinib in Advanced SarcomasCompletedNCT00464620Phase 2Results posted
• Sutent and Radiation as Treatment for Limited Extent Metastatic CancerCompletedNCT00463060Phase 1/2Results posted
• Sunitinib in Treating Patients With Brain Metastases Caused by Kidney Cancer or MelanomaCompletedNCT00462982Phase 2Results posted
• A Phase I Study of AC220 in Patients With Relapsed/Refractory Acute Myeloid Leukemia Regardless of FLT3 StatusCompletedNCT00462761Phase 1Results posted
• Trial of Gemcitabine, Carboplatin, and Sorafenib in Chemotherapy-naive Patients With Advanced/Metastatic Bladder CarcinomaCompletedNCT00461851Phase 2Results posted
• A Study of Tarceva (Erlotinib) in Combination With Gemcitabine in Unresectable and/or Metastatic Cancer of the Pancreas: Relationship Between Skin Toxicity and SurvivalCompletedNCT00461708Phase 2Results posted
• Study With AG-013736 Combined With Chemotherapy And Bevacizumab In Patients With Metastatic Colorectal CancerCompletedNCT00460603Phase 1/2Results posted
• Sunitinib in Treating Patients With Kidney Cancer That Cannot Be Removed by SurgeryCompletedNCT00459979Phase 2Results posted
• Sunitinib in Treating Patients With Locally Recurrent or Metastatic Kidney CancerCompletedNCT00459875Phase 2Results posted
• Pazopanib in Treating Patients With Malignant Pleural MesotheliomaCompletedNCT00459862Phase 2Results posted
• Pazopanib in Treating Patients With Recurrent GlioblastomaCompletedNCT00459381Phase 2Results posted
• Dasatinib in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung CancerCompletedNCT00459342Phase 2Results posted
• Vandetanib, Carboplatin, and Paclitaxel in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer That Can Be Removed by SurgeryTerminatedNCT00459121Phase 2Results posted
• Dasatinib in Treating Patients With Advanced Liver Cancer That Cannot Be Removed by SurgeryTerminatedNCT00459108Phase 2Results posted
• Docetaxel in Combination With Zactima (ZD6474) in Patients With Locally Advanced Squamous Cell Carcinoma of the the Head and NeckCompletedNCT00459043Phase 2Results posted
• Chemotherapy With or Without Imatinib and/or Peripheral Stem Cell Transplant in Acute Lymphoblastic LeukemiaCompletedNCT00458848Phase 2Results posted
• A Phase I/II Study of Sunitinib Malate (SU011248) In Patients With Gastrointestinal Stromal Tumor (GIST)CompletedNCT00457743Phase 1/2Results posted
• Study Of FOLFIRI Chemotherapy With Or Without Sunitinib In Patients With Metastatic Colorectal CancerCompletedNCT00457691Phase 3Results posted
• A Study In Patients With Non-Small Cell Lung Cancer To Test If Erlotinib Plus SU011248 Is Better Than Erlotinib AloneCompletedNCT00457392Phase 3Results posted
• AZD2171 in Addition to Fulvestrant in Patients With Advanced Breast Cancer.CompletedNCT00454805Phase 2Results posted
• Investigational Agent AG-013736 In Combinations With Standard Of Care Treatments For Patient's With Advanced Solid TumorCompletedNCT00454649Phase 1Results posted
• Pazopanib Hydrochloride After Leuprolide Acetate or Goserelin Acetate in Treating Patients With Relapsed Prostate CancerCompletedNCT00454571Phase 2Results posted
• Pazopanib Hydrochloride in Treating Patients With Advanced Neuroendocrine CancerCompletedNCT00454363Phase 2Results posted
• Pemetrexed Disodium With or Without Sorafenib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerCompletedNCT00454194Phase 2Results posted
• Pazopanib Hydrochloride in Treating Patients With Stage IV or Recurrent Nasopharyngeal CancerCompletedNCT00454142Phase 2Results posted
• A Phase II, Double Blind Study of 2 Doses of ZACTIMA™(ZD6474) in Combination With FOLFIRI vs FOLFIRI Alone for the Treatment of Colorectal Cancer in PatientsCompletedNCT00454116Phase 2Results posted
• Sunitinib in Refractory Adrenocortical CarcinomaCompletedNCT00453895Phase 2Results posted
• A Study of Changes in FDG- and FLT-PET Imaging in Patients With Non-Small Cell Lung Cancer Following Treatment With ErlotinibCompletedNCT00453362Phase 1/2Results posted
• Sunitinib in Treating Patients With Metastatic Germ Cell Tumors That Have Relapsed or Not Responded to TreatmentCompletedNCT00453310Phase 2Results posted
• Cisplatin or Carboplatin, and Etoposide With or Without Sunitinib Malate in Treating Patients With Extensive-Stage Small Cell Lung CancerCompletedNCT00453154Phase 1/2Results posted
• Phase I Study of Dasatinib (BMS-354825) and Capecitabine for Women With Advanced Breast CancerCompletedNCT00452673Phase 1Results posted
• A Study of Enzastaurin and Erlotinib in Participants With Solid Tumors and Lung CancerCompletedNCT00452413Phase 1/2Results posted
• Mitoxantrone, Prednisone Plus Sorafenib in Taxane-Refractory Metastatic Hormone Refractory Prostate Cancer (HRPC)TerminatedNCT00452387Phase 2Results posted
• Sunitinib in Treating Patients With Myelodysplastic Syndromes or Chronic Myelomonocytic LeukemiaCompletedNCT00451048Phase 2Results posted
• A Phase III Randomized, Double-blind, Placebo Controlled Trial Comparing the Efficacy of Gemcitabine, Cisplatin and Sorafenib to Gemcitabine, Cisplatin and Placebo in First-Line Treatment of Patients With Stage IIIb With Effusion and Stage IV Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00449033Phase 3Results posted
• Erlotinib (Tarceva) During First Line Standard Platinum Containing Chemo for Advanced Squamous Cell Head and Neck CancerTerminatedNCT00448240Phase 2/3Results posted
• BrUOG-PA-209: Lapatinib and Gemcitabine for Metastatic Pancreaticobiliary CancerTerminatedNCT00447122Phase 1Results posted
• Study Of AG-013736 (Axitinib) In Patients With Advanced Solid TumorsCompletedNCT00447005Phase 1Results posted
• Phase III Study (Tarceva®) vs Chemotherapy to Treat Advanced Non-Small Cell Lung Cancer in Patients With Mutations in the TK Domain of EGFRCompletedNCT00446225Phase 3Results posted
• Efficacy and Safety Study of Fostamatinib Tablets to Treat B-cell LymphomaCompletedNCT00446095Phase 1/2Results posted
• S0636: Erlotinib and Bevacizumab in Never-Smokers With Stage IIIB or Stage IV Primary Non-Small Cell Lung CancerCompletedNCT00445848Phase 2Results posted
• Erlotinib and Sorafenib in Treating Patients With Progressive or Recurrent Glioblastoma MultiformeCompletedNCT00445588Phase 2Results posted
• Vandetanib to Treat Women With Ovarian, Fallopian Tube, or Primary Peritoneal CancerTerminatedNCT00445549Phase 2Results posted
• A Phase 1/2 Study of HKI-272 (Neratinib) in Combination With Paclitaxel (Taxol) in Subjects With Solid Tumors and Breast CancerCompletedNCT00445458Phase 1/2Results posted
• Lapatinib and Bevacizumab for Metastatic Breast CancerCompletedNCT00444535Phase 2Results posted
• A Treatment Protocol For Patients Continuing From A Prior SU011248 Protocol.CompletedNCT00443534Not applicableResults posted
• Erlotinib and Avastin in Patients With Cancer of the Esophagus or Gastroesophageal JunctionTerminatedNCT00442507Phase 2Results posted
• Zactima With Temodar During Radiation Treatment for Newly Diagnosed Stage IV Brain TumorsCompletedNCT00441142Phase 1/2Results posted
• Study of Dasatinib and Docetaxel in Metastatic Hormone Refractory Prostate CancerCompletedNCT00439270Phase 1/2Results posted
• Dasatinib in Relapsed Chronic Lymphocytic LeukemiaCompletedNCT00438854Phase 2Results posted
• AZD2171 to Treat Prostate CancerCompletedNCT00436956Phase 2Results posted
• Lapatinib and Topotecan in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer That Did Not Respond to Cisplatin or CarboplatinCompletedNCT00436644Phase 2Results posted
• Dasatinib in Treating Patients With Stage III Melanoma That Cannot Be Removed By Surgery or Stage IV MelanomaCompletedNCT00436605Phase 2Results posted
• S0635: Erlotinib and Bevacizumab in Stage IIIB and IV Bronchioloalveolar CarcinomaCompletedNCT00436332Phase 2Results posted
• Sorafenib and Bevacizumab to Treat Ovarian, Fallopian and Peritoneal CancerCompletedNCT00436215Phase 2Results posted
• A Study Of Sunitinib In Combination With Capecitabine Compared With Capecitabine In Patients With Breast CancerCompletedNCT00435409Phase 3Results posted
• A Study of Sunitinib in Combination With Bevacizumab and Paclitaxel in Previously Untreated Patients With Metastatic Breast Cancer (SABRE-B)TerminatedNCT00434356Phase 2Results posted
• A Study of Sunitinib in Combination With Bevacizumab, Carboplatin, and Paclitaxel in Patients With Advanced Non-Small Cell Lung Cancer (SABRE-L)TerminatedNCT00434226Phase 2Results posted
• Phase II Study of Sunitinib Malate Following Hepatic Artery EmbolizationCompletedNCT00434109Phase 2Results posted
• Phase II Trial of BIBW 2992 in Patients With HER2-positive Metastatic Breast Cancer After Failure of Trastuzumab TherapyCompletedNCT00431067Phase 2Results posted
• Pazopanib Plus Lapatinib Compared to Lapatinib Alone and Pazopanib Alone In Subjects With Metastatic Cervical CancerCompletedNCT00430781Phase 2Results posted
• A Phase II Study of Dasatinib in the Treatment of Relapsed or Plateau Phase Multiple MyelomaCompletedNCT00429949Phase 2Results posted
• Neoadjuvant Study With Chemotherapy, Lapatinib And Trastuzumab In Breast CancerCompletedNCT00429299Phase 2Results posted
• A Study Of Sunitinib Compared To Placebo For Patients With Advanced Pancreatic Islet Cell TumorsTerminatedNCT00428597Phase 3Results posted
• A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.CompletedNCT00428220Not applicableResults posted

← Tyrosine Kinase Inhibitors overview